Načítá se...

Luteinizing hormone compromises the in vivo anti-tumor effect of cisplatin on human epithelial ovarian cancer cells

Platinum-based chemotherapy is the most common therapeutic regimen used to treat patients with ovarian cancer. However, the emergence of drug resistance to platinum compromises the clinical success of this treatment. Epithelial ovarian cancer is usually accompanied by an increased level of luteinizi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Lett
Hlavní autoři: Huang, Yan, Zhou, Yuqi, Xia, Lingfang, Tang, Jia, Wen, Hao, Zhang, Meiqin
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5778858/
https://ncbi.nlm.nih.gov/pubmed/29435048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7655
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!